Mosorin Matti-Aleksi, Lantos Maté, Juvonen Tatu, Biancari Fausto
Department of Surgery, Oulu University Hospital , Oulu , Finland.
Front Surg. 2015 Jan 21;2:2. doi: 10.3389/fsurg.2015.00002. eCollection 2015.
The aim of this study was to evaluate the role of coronary artery bypass grafting (CABG) in patients with out-of-hospital cardiac arrest (OHCA).
The immediate and 5-year outcome after CABG of a consecutive series of 48 patients who survived OHCA was compared with those of control patients having had a recent myocardial infarction without ventricular arrhythmias.
All OHCA patients were found to have suffered myocardial infarction-related cardiac arrest. The mean delay from OHCA to CABG was 10.3 ± 13.0 days. Despite not statistically significant, the risk of 30-day postoperative mortality was higher among OHCA patients than control patients (6.3 vs. 0%, p = 0.24, propensity score adjusted analysis: p = 1.00). Cardioverter defibrillator was implanted in two patients who were alive 3.8 and 4.4 years after CABG, respectively. At 5-year, the overall survival rate was 80.7% in OHCA patients and 84.5% in control patients (p = 0.98, propensity score adjusted analysis: p = 0.87), and survival freedom from fatal cardiac event was 86.1% in OHCA patients and 86.5% in control patients (p = 0.61; propensity score adjusted analysis: p = 0.90).
Early and 5-year survival rates after CABG in OHCA patients are excellent even when cardioverter defibrillator is very selectively implanted. The early and intermediate results CABG suggest a confident approach toward surgical revascularization in this critically ill patient population.
本研究旨在评估冠状动脉旁路移植术(CABG)在院外心脏骤停(OHCA)患者中的作用。
将48例OHCA存活患者连续进行CABG后的近期和5年结局与近期发生心肌梗死且无室性心律失常的对照患者进行比较。
所有OHCA患者均发生了与心肌梗死相关的心脏骤停。从OHCA到CABG的平均延迟时间为10.3±13.0天。尽管无统计学意义,但OHCA患者术后30天死亡率高于对照患者(6.3%对0%,p = 0.24,倾向评分调整分析:p = 1.00)。两名患者在CABG后分别存活3.8年和4.4年时植入了心脏复律除颤器。5年时,OHCA患者的总生存率为80.7%,对照患者为84.5%(p = 0.98,倾向评分调整分析:p = 0.87),无致命心脏事件的生存率在OHCA患者中为86.1%,对照患者中为86.5%(p = 0.61;倾向评分调整分析:p = 0.90)。
即使非常选择性地植入心脏复律除颤器,OHCA患者CABG后的早期和5年生存率也很高。CABG的早期和中期结果表明,对于这一危重症患者群体,手术血运重建是一种可靠的方法。